COPD-Related Bellerophon Therapeutics Phase 2 Trial of INOpulse for Pulmonary Hypertension Fully Enrolled
Bellerophon Therapeutics, who recently completed enrollment for a Phase 2 clinical trial evaluating INOpulse in patients with pulmonary hypertension, has fully enrolled another Phase 2 clinical trial, this time evaluating INOpulse in 159 pulmonary hypertension…